{"disease":{"id":"carbapenem-resistant-bacterial-infection","name":"carbapenem resistant bacterial infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07226557","title":"Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT07004049","title":"Optimising TREATment for Severe Gram-Negative Bacterial Infections","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"National University of Singapore","has_results":false},{"nct_id":"NCT06392568","title":"Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Abderrahmane Mami Hospital","has_results":false},{"nct_id":"NCT06167083","title":"Machine Learning in the ICU: Predicting Mortality in Bloodstream Infections (ICU:Intensive Care Unit)","phase":"","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Kocaeli University","has_results":false},{"nct_id":"NCT05210387","title":"Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections","phase":"NA","overall_status":"TERMINATED","enrollment_count":107,"lead_sponsor_name":"Hospital Moinhos de Vento","has_results":false},{"nct_id":"NCT06542965","title":"Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Dokuz Eylul University","has_results":false},{"nct_id":"NCT05988177","title":"Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT04785924","title":"Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}